Coherence for Health

Innovation for New Medicines for Infectious Diseases

image of Coherence for Health

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance.



What Are the Problems?

Why Is It in the Economic Interest of OECD Countries to Address these Problems?

This chapter outlines the impact of neglected infectious diseases in developing countries by citing current morbidity and mortality rates, elucidating the economic burden infectious diseases pose, highlighting the problems of lacking pharmaceutical products, explaining the drug research and development/innovation process, and discussing the economics of drug development. The chapter closes with a section on why OECD is interested in neglected and emerging infectious diseases that mainly affect developing countries.


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error